Oral antidiabetic for the metabolic control in gestational diabetes
Acta Médica del Centro, 2016 The search for alternative therapies to insulin for the treatment of gestational diabetes goes back to studies from the decade of 1970 and 1980. The oral hypoglycemic agents have emerged as an effective alternative for metabolic control of gestational ...
Yoany Marín Tápanes +1 more
doaj
Antidiabetic effect of Psychotria malayana Jack in induced type 1 diabetic rat
Medisains, 2020 Background: Therapies for hyperglycemic treatment, including insulin and oral diabetes medications, have been confirmed to cause several side effects. Thus, finding new drugs with fewer side effects is of high importance.
Fairuz Fairuz +2 more
doaj +1 more source
Patterns of Adherence to Oral Hypoglycemic Agents and Glucose Control among Primary Care Patients with Type 2 Diabetes [PDF]
, 2016 Researchers sought to examine whether there are patterns of oral hypoglycemic-agent adherence among primary-care patients with type 2 diabetes that are related to patient characteristics and clinical outcomes.
de Vries McClintock, Heather F +3 more
core +1 more source
Clinical Medicine Insights: Case Reports, 2018 Blood glucose management in patients undergoing dialysis is clinically challenging. In this population, most conventional oral hypoglycemic agents are contraindicated, especially from the perspective of pharmacokinetics. Dipeptidyl peptidase-4 inhibitors
Takumi Minezumi +5 more
doaj +1 more source
Research Progress in Bioactive Compounds in Medicine Food Homologous Plants for Intervention in Diabetes [PDF]
Shipin KexueDiabetes mellitus (DM) is a chronic, progressive systemic disease characterized by pancreatic β-cell dysfunction and insulin resistance. The primary symptom of this disease is elevated blood glucose levels. Medicine food homologous plants (MFP) contain a
ZHOU Yixia, QIN Luqi, DIAO Rao, ZHENG Jiahuan, LIU Jiameng, FAN Bei
doaj +1 more source
Ethnomedicinal survey of traditional antidiabetic plants in Baturraden and Sumbang
Medisains, 2020 Background: The scientific-based jamu development program enables the development of medicinal plants in the traditional medicine system that eventual-ly can be used in the formal healthcare system.
Wahyu Utaminingrum +2 more
doaj +1 more source
, 2015 Data are shown as mean ± SD*t-test was employed for comparisons between the hypoglycemic and non-hypoglycemic patients.Patient Profile and Parameters for Glycemic Variability Compared between Hypoglycemic and Non-hypoglycemic Patients.
Kiyotaka Ando (439636) +4 more
core +1 more source
Pleiotropic effects of hypoglycemic agents: implications in asthma and COPD
, 2018 Diabetes mellitus (DM) is a complex multifactorial disease due to the interaction between environmental noxae and genetic predisposition. Furthermore, an increased association between DM, especially Type 2 diabetes mellitus (T2DM), and the onset of ...
Paola Rogliani +11 more
core +1 more source
Analysis of Electrolyte Imbalance Especially Hypokalemia in Patients receiving Insulin and Oral Hypoglycemic Agents in Comparison with Patients Taking only Oral Hypoglycemic Agents in Type 2 Diabetes Mellitus Patients: A Comparative, Cross Sectional, Observational study [PDF]
, 2020 BACKGROUND: Exogenous Insulin is the commonly prescribed drug for patients with Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, Hyperkalemia. Insulin acts by promoting the glucose transport into the cells through GLUT 4 transporter.
Rahul, R
core
, 2012 Christian Díaz de León-Castañeda, Marina Altagracia-Martínez, Jaime Kravzov-Jinich, Ma del Rosario Cárdenas-Elizalde, Consuelo Moreno-Bonett, Juan Manuel Martínez-Núñ ...
Cárdenas-Elizalde MR +5 more
core